Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates

References

• Beck A, Wurch T, Bailly C, Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10:345-52; PMID:20414207; https://doi.org/10.1038/nri2747
   PubMed Web of Science ®Google Scholar
• Reichert JM. Antibodies to watch in 2017. MAbs 2017; 9:167-81; PMID:27960628; https://doi.org/10.1080/19420862.2016.1269580
   PubMed Web of Science ®Google Scholar
• Beck A, Reichert JM. Antibody-drug conjugates: Present and future. MAbs 2014; 6:15-7; PMID:24423577; https://doi.org/10.4161/mabs.27436
   PubMed Web of Science ®Google Scholar
• Junutula JR, Gerber HP. Next-Generation antibody-drug conjugates (ADCs) for cancer therapy. ACS Med Chem Lett 2016; 7:972-3; PMID:27882192; https://doi.org/10.1021/acsmedchemlett.6b00421
   PubMed Web of Science ®Google Scholar
• Beck A, Terral G, Debaene F, Wagner-Rousset E, Marcoux J, Janin-Bussat MC, Colas O, Van Dorsselaer A, Cianférani S. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates. Expert Rev Proteomics 2016; 13:157-83; PMID:26653789; https://doi.org/10.1586/14789450.2016.1132167
   PubMed Web of Science ®Google Scholar
• Loganzo F, Sung M, Gerber HP. Mechanisms of resistance to antibody-drug conjugates. Mol Cancer Ther 2016; 15:2825-34; PMID:27780876; https://doi.org/10.1158/1535-7163.MCT-16-0408
   PubMed Web of Science ®Google Scholar
• Dennler P, Fischer E, Schibli R. Antibody conjugates: From heterogeneous populations to defined reagents. Antibodies 2015; 4:197-224; https://doi.org/10.3390/antib4030197
   Web of Science ®Google Scholar
• Beck A, Lambert J, Sun M, Lin K. Fourth world antibody-drug conjugate summit: February 29-March 1, 2012, Frankfurt, Germany. MAbs 2012; 4:637-47; PMID:22909934; https://doi.org/10.4161/mabs.21697
   PubMedGoogle Scholar
• Roberts SA, Andrews PA, Blanset D, Flagella KM, Gorovits B, Lynch CM, Martin PL, Kramer-Stickland K, Thibault S, Warner G. Considerations for the nonclinical safety evaluation of antibody drug conjugates for oncology. Regul Toxicol Pharmacol 2013; 67:382-91; PMID:24012707; https://doi.org/10.1016/j.yrtph.2013.08.017
   PubMed Web of Science ®Google Scholar
• Gordon MR, Canakci M, Li L, Zhuang J, Osborne B, Thayumanavan S. Field guide to challenges and opportunities in antibody-drug conjugates for chemists. Bioconjug Chem 2015; 26:2198-215; PMID:26308881; https://doi.org/10.1021/acs.bioconjchem.5b00399
   PubMed Web of Science ®Google Scholar
• Junutula JR, Raab H, Clark S, Bhakta S, Leipold DD, Weir S, Chen Y, Simpson M, Tsai SP, Dennis MS, et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat Biotechnol 2008; 26:925-32; PMID:18641636; https://doi.org/10.1038/nbt.1480
   PubMed Web of Science ®Google Scholar
• Panowski S, Bhakta S, Raab H, Polakis P, Junutula JR. Site-specific antibody drug conjugates for cancer therapy. MAbs 2014; 6:34-45; PMID:24423619; https://doi.org/10.4161/mabs.27022
   PubMed Web of Science ®Google Scholar
• Dennler P, Chiotellis A, Fischer E, Bregeon D, Belmant C, Gauthier L, Lhospice F, Romagne F, Schibli R. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates. Bioconjug Chem 2014; 25:569-78; PMID:24483299; https://doi.org/10.1021/bc400574z
   PubMed Web of Science ®Google Scholar
• Farias SE, Strop P, Delaria K, Galindo Casas M, Dorywalska M, Shelton DL, Pons J, Rajpal A. Mass spectrometric characterization of transglutaminase based site-specific antibody-drug conjugates. Bioconjug Chem 2014; 25:240-50; PMID:24359082; https://doi.org/10.1021/bc4003794
   PubMed Web of Science ®Google Scholar
• Axup JY, Bajjuri KM, Ritland M, Hutchins BM, Kim CH, Kazane SA, Halder R, Forsyth JS, Santidrian AF, Stafin K, et al. Synthesis of site-specific antibody-drug conjugates using unnatural amino acids. P Natl Acad Sci USA 2012; 109:16101-6; PMID:22988081; https://doi.org/10.1073/pnas.1211023109
   PubMed Web of Science ®Google Scholar
• Smith EL, Giddens JP, Iavarone AT, Godula K, Wang LX, Bertozzi CR. Chemoenzymatic Fc glycosylation via engineered aldehyde tags. Bioconjug Chem 2014; 25:788-95; PMID:24702330; https://doi.org/10.1021/bc500061s
   PubMed Web of Science ®Google Scholar
• Kolodych S, Koniev O, Baatarkhuu Z, Bonnefoy JY, Debaene F, Cianferani S, Van Dorsselaer A, Wagner A. CBTF: New amine-to-thiol coupling reagent for preparation of antibody conjugates with increased plasma stability. Bioconjug Chem 2015; 26:197-200; PMID:25614935; https://doi.org/10.1021/bc500610g
   PubMed Web of Science ®Google Scholar
• Koniev O, Kolodych S, Baatarkhuu Z, Stojko J, Eberova J, Bonnefoy JY, Cianférani S, Van Dorsselaer A, Wagner A. MAPN: First-in-Class reagent for kinetically resolved thiol-to-thiol conjugation. Bioconjug Chem 2015; 26:1863-7; PMID:26335849; https://doi.org/10.1021/acs.bioconjchem.5b00440
   PubMed Web of Science ®Google Scholar
• Beck A, Goetsch L, Dumontet C, Corvaïa N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov 2017; in press; PMID:28303026; https://doi.org/10.1038/nrd.2016.268
   PubMed Web of Science ®Google Scholar
• Strop P, Tran TT, Dorywalska M, Delaria K, Dushin R, Wong OK, Ho WH, Zhou D, Wu A, Kraynov E, et al. RN927C, a site-specific trop-2 antibody-drug conjugate (ADC) with enhanced stability, is highly efficacious in preclinical solid tumor models. Mol Cancer Ther 2016; 15:2698-708; PMID:27582525; https://doi.org/10.1158/1535-7163.MCT-16-0431
   PubMed Web of Science ®Google Scholar
• Zhou C, Lehar S, Gutierrez J, Rosenberger CM, Ljumanovic N, Dinoso J, Koppada N, Hong K, Baruch A, Carrasco-Triguero M, et al. Pharmacokinetics and pharmacodynamics of DSTA4637A: A novel THIOMAB antibody antibiotic conjugate against Staphylococcus aureus in mice. MAbs 2016; 8:1612-9; PMID:27653831; https://doi.org/10.1080/19420862.2016.1229722
   PubMed Web of Science ®Google Scholar
• de Goeij BE, Vink T, Ten Napel H, Breij EC, Satijn D, Wubbolts R, Miao D, Parren PW. Efficient payload delivery by a bispecific antibody-drug conjugate targeting HER2 and CD63. Mol Cancer Ther 2016; 15:2688-97; PMID:27559142; https://doi.org/10.1158/1535-7163.MCT-16-0364
   PubMed Web of Science ®Google Scholar
• Levengood MR, Zhang X, Hunter JH, Emmerton KK, Miyamoto JB, Lewis TS, Senter PD. Orthogonal cysteine protection enables homogeneous multi-drug antibody-drug conjugates. Angew Chem Int Ed Engl 2017; 56:733-7; PMID:27966822; https://doi.org/10.1002/anie.201608292
   PubMed Web of Science ®Google Scholar
• Rabuka D, Rush JS, deHart GW, Wu P, Bertozzi CR. Site-specific chemical protein conjugation using genetically encoded aldehyde tags. Nat Protoc 2012; 7:1052-67; PMID:22576105; https://doi.org/10.1038/nprot.2012.045
   PubMed Web of Science ®Google Scholar
• Agarwal P, Kudirka R, Albers AE, Barfield RM, de Hart GW, Drake PM, Jones LC, Rabuka D. Hydrazino-pictet-spengler ligation as a biocompatible method for the generation of stable protein conjugates. Bioconjug Chem 2013; 24:846-51; PMID:23731037; https://doi.org/10.1021/bc400042a
   PubMed Web of Science ®Google Scholar
• Kudirka R, Barfield RM, McFarland J, Albers AE, de Hart GW, Drake PM, Holder PG, Banas S, Jones LC, Garofalo AW, et al. Generating site-specifically modified proteins via a versatile and stable nucleophilic carbon ligation. Chem Biol 2015; 22:293-8; PMID:25619935; https://doi.org/10.1016/j.chembiol.2014.11.019
   PubMedGoogle Scholar
• York D, Baker J, Holder PG, Jones LC, Drake PM, Barfield RM, Bleck GT, Rabuka D. Generating aldehyde-tagged antibodies with high titers and high formylglycine yields by supplementing culture media with copper(II). BMC Biotechnol 2016; 16:23; PMID:26911368; https://doi.org/10.1186/s12896-016-0254-0
   PubMed Web of Science ®Google Scholar
• Holder PG, Jones LC, Drake PM, Barfield RM, Banas S, de Hart GW, Baker J, Rabuka D. Reconstitution of formylglycine-generating enzyme with copper(II) for aldehyde tag conversion. J Biol Chem 2015; 290:15730-45; PMID:25931126; https://doi.org/10.1074/jbc.M115.652669
   PubMed Web of Science ®Google Scholar
• Kudirka RA, Barfield RM, McFarland JM, Drake PM, Carlson A, Banas S, Zmolek W, Garofalo AW, Rabuka D. Site-specific tandem knoevenagel condensation-michael addition to generate antibody-drug conjugates. ACS Med Chem Lett 2016; 7:994-8; PMID:27882197; https://doi.org/10.1021/acsmedchemlett.6b00253
   PubMed Web of Science ®Google Scholar
• Pillow TH, Tien J, Parsons-Reponte KL, Bhakta S, Li H, Staben LR, Li G, Chuh J, Fourie-O'Donohue A, Darwish M, et al. Site-specific trastuzumab maytansinoid antibody-drug conjugates with improved therapeutic activity through linker and antibody engineering. J Med Chem 2014; 57:7890-9; PMID:25191794; https://doi.org/10.1021/jm500552c
   PubMed Web of Science ®Google Scholar
• Marcoux J, Champion T, Colas O, Wagner-Rousset E, Corvaia N, Van Dorsselaer A, Beck A, Cianférani S. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate. Protein Sci 2015; 24:1210-23; PMID:25694334; https://doi.org/10.1002/pro.2666
   PubMed Web of Science ®Google Scholar
• Debaene F, Boeuf A, Wagner-Rousset E, Colas O, Ayoub D, Corvaia N, Van Dorsselaer A, Beck A, Cianférani S. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment. Anal Chem 2014; 86:10674-83; PMID:25270580; https://doi.org/10.1021/ac502593n
   PubMed Web of Science ®Google Scholar
• Ruotolo BT, Benesch JL, Sandercock AM, Hyung SJ, Robinson CV. Ion mobility-mass spectrometry analysis of large protein complexes. Nat Protoc 2008; 3:1139-52; PMID:18600219; https://doi.org/10.1038/nprot.2008.78
   PubMed Web of Science ®Google Scholar
• Pacholarz KJ, Porrini M, Garlish RA, Burnley RJ, Taylor RJ, Henry AJ, Barran PE. Dynamics of intact immunoglobulin G explored by drift-tube ion-mobility mass spectrometry and molecular modeling. Angew Chem Int Ed Engl 2014; 53:7765-9; PMID:24916519; https://doi.org/10.1002/anie.201402863
   PubMed Web of Science ®Google Scholar
• Tian Y, Han L, Buckner AC, Ruotolo BT. Collision induced unfolding of intact antibodies: Rapid characterization of disulfide bonding patterns, glycosylation, and structures. Anal Chem 2015; 87:11509-15; PMID:26471104; https://doi.org/10.1021/acs.analchem.5b03291
   PubMed Web of Science ®Google Scholar
• Terral G, Beck A, Cianferani S. Insights from native mass spectrometry and ion mobility-mass spectrometry for antibody and antibody-based product characterization. J Chromatogr B Analyt Technol Biomed Life Sci 2016; 1032:79-90; PMID:27108304; https://doi.org/10.1016/j.jchromb.2016.03.044
   PubMed Web of Science ®Google Scholar
• Bush MF, Hall Z, Giles K, Hoyes J, Robinson CV, Ruotolo BT. Collision cross sections of proteins and their complexes: A calibration framework and database for gas-phase structural biology. Anal Chem 2010; 82:9557-65; PMID:20979392; https://doi.org/10.1021/ac1022953
   PubMed Web of Science ®Google Scholar
• Eschweiler JD, Rabuck-Gibbons JN, Tian Y, Ruotolo BT. CIUSuite: A quantitative analysis package for collision induced unfolding measurements of gas-phase protein ions. Anal Chem 2015; 87:11516-22; PMID:26489593; https://doi.org/10.1021/acs.analchem.5b03292
   PubMed Web of Science ®Google Scholar
• Albers AE, Garofalo AW, Drake PM, Kudirka R, de Hart GW, Barfield RM, Baker J, Banas S, Rabuka D. Exploring the effects of linker composition on site-specifically modified antibody-drug conjugates. Eur J Med Chem 2014; 88:3-9; PMID:25176286; https://doi.org/10.1016/j.ejmech.2014.08.062
   PubMed Web of Science ®Google Scholar
• Drake PM, Albers AE, Baker J, Banas S, Barfield RM, Bhat AS, de Hart GW, Garofalo AW, Holder P, Jones LC, et al. Aldehyde tag coupled with HIPS chemistry enables the production of ADCs conjugated site-specifically to different antibody regions with distinct in vivo efficacy and PK outcomes. Bioconjug Chem 2014; 25:1331-41; PMID:24924618; https://doi.org/10.1021/bc500189z
   PubMed Web of Science ®Google Scholar